Physician profile
Christopher Hill
NPI 1366429813
$4,135.94
in general payments reported to CMS, 2019-2025
38 companies · $21.58 in 2025
The $21.58 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $487 · 2021: $834 · 2022: $981 · 2023: $570 · 2024: $685 · 2025: $21.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,275.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $688.32 | 2019-2022 | |
| Pfizer INC. | $443.69 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $378.57 | 2023-2024 | Gemtesa, Orgovyx |
| Hollister Incorporated | $244.31 | 2021-2022 | |
| Abbvie INC. | $239.53 | 2023-2024 | |
| Dendreon Pharmaceuticals LLC | $216.08 | 2019-2022 | |
| Urogen Pharma, INC. | $163.85 | 2022-2024 | Jelmyto |
| Blue Earth Diagnostics | $162.43 | 2019-2021 | |
| Urovant Sciences INC | $144.47 | 2022 | |
| Allergan, INC. | $139.92 | 2019-2022 | |
| Caldera Medical, INC | $128.63 | 2022 | |
| Angiodynamics, INC. | $116.49 | 2022 | |
| Coloplast Corp | $100.07 | 2019-2023 | Coloplast Tfl Drive, Porges Coloplast |
| Astrazeneca Pharmaceuticals Lp | $97.97 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $94.07 | 2020-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipla USA INC. | $83.72 | 2021 | |
| Ferring Pharmaceuticals INC. | $81.62 | 2019 | |
| Myriad Genetic Laboratories, INC. | $57.12 | 2021-2024 | Prolaris |
| Verity Pharmaceuticals INC. | $56.66 | 2023-2024 | Tlando, Trelstar |
| Ambu INC. | $54.95 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $54.49 | 2023-2025 | Pylarify |
| 180 Medical, INC. | $47.09 | 2021-2022 | |
| Amgen INC. | $45.41 | 2019-2022 | |
| Axonics, INC. | $43.02 | 2020-2023 | Axonics |
| Agiliti Health, INC. | $42.73 | 2023 | Soltive, Sonablate, Versapulse Powersuite 80w |
| Myovant Sciences INC. | $42.23 | 2021-2022 | |
| Boston Scientific Corporation | $28.79 | 2021-2023 | Lithovue |
| Tolmar Pharmaceuticals, INC. | $24.65 | 2020 | |
| Merck Sharp & Dohme LLC | $19.23 | 2021 | |
| Clovis Oncology, INC. | $18.57 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.27 | 2022 | |
| Medtronic USA, INC. | $13.64 | 2020 | |
| Endo Pharmaceuticals INC. | $11.83 | 2020 | |
| Medtronic, INC. | $11.66 | 2022 | |
| Janssen Biotech, INC. | $10.86 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$256,451.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.